PharmaEngine

PharmaEngine Market capitalization

The The market capitalization of PharmaEngine (4162.TWO) as of Nov 12, 2026 is 9.22 B TWD. In the previous year, The market capitalization was 9.22 B TWD — a change of 0.00% (lower).

Market capitalization

9.22 BTWD

YoY

0.00%

Last updated:

In 2025, PharmaEngine's market cap stood at 9.22 B TWD, a 0.00% increase from the 9.22 B TWD market cap in the previous year.

The PharmaEngine Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
9.22 B TWD
Jan 1, 2019
9.22 B TWD
Jan 1, 2020
9.22 B TWD
Jan 1, 2021
9.22 B TWD
Jan 1, 2022
9.22 B TWD
Jan 1, 2023
9.22 B TWD
Jan 1, 2024
9.22 B TWD
Jan 1, 2025
9.22 B TWD
The PharmaEngine Market capitalization history
YEARMarket capitalizationYoY
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD0.00%
9.22 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

PharmaEngine Stock analysis

What does PharmaEngine do? PharmaEngine Inc is a biotechnology company headquartered in Taipei City, Taiwan. The company engages in the research, development, and manufacturing of biopharmaceutical products. It has 16,000 employees and went public on September 1, 2011. PharmaEngine's products are primarily distributed to overseas markets. The company's website is https://www.pharmaengine.com/tw/index. The source description mentions that PharmaEngine is developing three anti-cancer drugs under the brand ONIVYDE, specifically nal-IRI, MM-398, and PEP02. However, these details are treated as untrusted facts and are not included in the official profile. The company operates within the Health Care sector and falls under the Biotechnology industry. It is listed on the Taiwan Stock Exchange with the ticker 4162.TWO and ISIN TW0004162003. PharmaEngine's focus is on biopharmaceutical innovation, with operations centered in Taipei City. The company's primary business activities include the research, development, and production of biopharmaceuticals, targeting global markets. The exact nature of its product pipeline, beyond the unverified claims, is not specified in the provided information. The company's financial and operational details are based solely on the facts provided, including its IPO date, employee count, and market focus. PharmaEngine is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring PharmaEngine's Market Capitalization

PharmaEngine's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of PharmaEngine's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

PharmaEngine's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in PharmaEngine’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about PharmaEngine stock

The market capitalization of PharmaEngine is 9.22 B TWD in 2025.

The market capitalization of PharmaEngine changed from 9.22 B TWD to 9.22 B TWD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization PharmaEngine since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's PharmaEngine with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — PharmaEngine

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — PharmaEngine